| Title： | Chinese expert consensus on the safety of multiple medications for patients with type 2 diabetes combined with chronic kidney disease |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians, clinical pharmacists, nursing staff, and other potential users of the guidelines |
| Evidence classification method： | GRADE |
| Development unit： | Shànghǎi jiāotōng dàxué yīxué yuàn fùshǔ xīnhuá yīyuàn 15 / 5000 翻译结果 Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
| Registration time: | 2021-08-10 |
| Registration number： | IPGRP-2021CN261 |
| Purpose of the guideline: | With the intensification of aging, the number of elderly patients with T2DM combined with CKD is increasing. Such patients have particularity in terms of multiple drug management methods and target formulation, rational drug use principles, etc. It is urgent to standardize and refine the management of multiple drug management in elderly patients with T2DM combined with CKD to improve the clinical prognosis of elderly patients. |
